TY - JOUR
T1 - Worldwide Prevalence and Burden of Functional Gastrointestinal Disorders, Results of Rome Foundation Global Study
AU - Sperber, Ami D.
AU - Bangdiwala, Shrikant I.
AU - Drossman, Douglas A.
AU - Ghoshal, Uday C.
AU - Simren, Magnus
AU - Tack, Jan
AU - Whitehead, William E.
AU - Dumitrascu, Dan L.
AU - Fang, Xuicai
AU - Fukudo, Shin
AU - Kellow, John
AU - Okeke, Edith
AU - Quigley, Eamonn M.M.
AU - Schmulson, Max
AU - Whorwell, Peter
AU - Archampong, Timothy
AU - Adibi, Payman
AU - Andresen, Viola
AU - Benninga, Marc A.
AU - Bonaz, Bruno
AU - Bor, Serhat
AU - Fernandez, Luis Bustos
AU - Choi, Suck Chei
AU - Corazziari, Enrico S.
AU - Francisconi, Carlos
AU - Hani, Albis
AU - Lazebnik, Leonid
AU - Lee, Yeong Yeh
AU - Mulak, Agata
AU - Rahman, M. Masudur
AU - Santos, Javier
AU - Setshedi, Mashiko
AU - Syam, Ari Fahrial
AU - Vanner, Stephen
AU - Wong, Reuben K.
AU - Lopez-Colombo, Aurelio
AU - Costa, Valeria
AU - Dickman, Ram
AU - Kanazawa, Motoyori
AU - Keshteli, Ammar Hassanzadeh
AU - Khatun, Rutaba
AU - Maleki, Iradj
AU - Poitras, Pierre
AU - Pratap, Nitesh
AU - Stefanyuk, Oksana
AU - Thomson, Sandie
AU - Zeevenhooven, Judith
AU - Palsson, Olafur S.
N1 - Funding Information:
Funding The study was funded, in part, by research grants from Ironwood , Shire , Allergan , and Takeda . The study in Malaysia was funded by the Fundamental Research Grant Scheme (FRGS) of the Ministry of Education of Malaysia (Reference: 203.PPSP.6171192). The study in Israel was funded by Takeda-Israel . The study in Romania was funded by the Romanian Society of Neurogastroenterology . None of the funders was involved in the planning, design, implementation, statistical analyses or any other aspect of the study including preparation of the paper or knowledge of its contents.
Publisher Copyright:
© 2021 The Authors
Copyright:
Copyright 2020 Elsevier B.V., All rights reserved.
PY - 2021/1
Y1 - 2021/1
N2 - Background & Aims: Although functional gastrointestinal disorders (FGIDs), now called disorders of gut-brain interaction, have major economic effects on health care systems and adversely affect quality of life, little is known about their global prevalence and distribution. We investigated the prevalence of and factors associated with 22 FGIDs, in 33 countries on 6 continents. Methods: Data were collected via the Internet in 24 countries, personal interviews in 7 countries, and both in 2 countries, using the Rome IV diagnostic questionnaire, Rome III irritable bowel syndrome questions, and 80 items to identify variables associated with FGIDs. Data collection methods differed for Internet and household groups, so data analyses were conducted and reported separately. Results: Among the 73,076 adult respondents (49.5% women), diagnostic criteria were met for at least 1 FGID by 40.3% persons who completed the Internet surveys (95% confidence interval [CI], 39.9–40.7) and 20.7% of persons who completed the household surveys (95% CI, 20.2–21.3). FGIDs were more prevalent among women than men, based on responses to the Internet survey (odds ratio, 1.7; 95% CI, 1.6–1.7) and household survey (odds ratio, 1.3; 95% CI, 1.3–1.4). FGIDs were associated with lower quality of life and more frequent doctor visits. Proportions of subjects with irritable bowel syndrome were lower when the Rome IV criteria were used, compared with the Rome III criteria, in the Internet survey (4.1% vs 10.1%) and household survey (1.5% vs 3.5%). Conclusions: In a large-scale multinational study, we found that more than 40% of persons worldwide have FGIDs, which affect quality of life and health care use. Although the absolute prevalence was higher among Internet respondents, similar trends and relative distributions were found in people who completed Internet vs personal interviews.
AB - Background & Aims: Although functional gastrointestinal disorders (FGIDs), now called disorders of gut-brain interaction, have major economic effects on health care systems and adversely affect quality of life, little is known about their global prevalence and distribution. We investigated the prevalence of and factors associated with 22 FGIDs, in 33 countries on 6 continents. Methods: Data were collected via the Internet in 24 countries, personal interviews in 7 countries, and both in 2 countries, using the Rome IV diagnostic questionnaire, Rome III irritable bowel syndrome questions, and 80 items to identify variables associated with FGIDs. Data collection methods differed for Internet and household groups, so data analyses were conducted and reported separately. Results: Among the 73,076 adult respondents (49.5% women), diagnostic criteria were met for at least 1 FGID by 40.3% persons who completed the Internet surveys (95% confidence interval [CI], 39.9–40.7) and 20.7% of persons who completed the household surveys (95% CI, 20.2–21.3). FGIDs were more prevalent among women than men, based on responses to the Internet survey (odds ratio, 1.7; 95% CI, 1.6–1.7) and household survey (odds ratio, 1.3; 95% CI, 1.3–1.4). FGIDs were associated with lower quality of life and more frequent doctor visits. Proportions of subjects with irritable bowel syndrome were lower when the Rome IV criteria were used, compared with the Rome III criteria, in the Internet survey (4.1% vs 10.1%) and household survey (1.5% vs 3.5%). Conclusions: In a large-scale multinational study, we found that more than 40% of persons worldwide have FGIDs, which affect quality of life and health care use. Although the absolute prevalence was higher among Internet respondents, similar trends and relative distributions were found in people who completed Internet vs personal interviews.
KW - DGBI
KW - epidemiology
KW - IBS
UR - http://www.scopus.com/inward/record.url?scp=85097793980&partnerID=8YFLogxK
U2 - 10.1053/j.gastro.2020.04.014
DO - 10.1053/j.gastro.2020.04.014
M3 - Article
AN - SCOPUS:85097793980
SN - 0016-5085
VL - 160
SP - 99-114.e3
JO - Gastroenterology
JF - Gastroenterology
IS - 1
ER -